Table 3.
Comparison of ASR of major cancer types, 2012
| Tumor site | Cases | Rank | Incidence rate (1/105) | Percentage (%) | ASR World (1/105) | P † | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| USZ | RSX | USZ | RSX | USZ | RSX | USZ | RSX | USZ | RSX | ||
| Male | |||||||||||
| Lung (C33–34) | 786 | 72 | 1 | 3 | 67.9 | 33.4 | 25.2 | 9.3 | 46.5 | 30.0 | < 0.01 |
| Stomach (C16) | 469 | 389 | 2 | 1 | 40.5 | 180.4 | 15.1 | 50.2 | 28.5 | 162.0 | < 0.01 |
| Colorectal (C18–21) | 381 | 29 | 3 | 5 | 32.9 | 13.7 | 12.2 | 3.7 | 22.8 | 11.9 | < 0.01 |
| Liver (C22) | 279 | 46 | 4 | 4 | 24.1 | 21.3 | 9.0 | 5.9 | 17.4 | 18.5 | |
| Esophagus (C15) | 266 | 172 | 5 | 2 | 23.0 | 79.8 | 8.5 | 22.2 | 15.7 | 72.1 | < 0.01 |
| Kidney (C64–66,68) | 114 | 5 | 6 | 8 | 9.9 | 2.3 | 3.7 | 0.6 | 6.9 | 2.2 | < 0.05 |
| Prostate (C61) | 106 | 2 | 7 | 10 | 9.2 | 0.9 | 3.4 | 0.3 | 5.3 | 0.7 | < 0.01 |
| Leukemia (C91–95) | 104 | 9 | 8 | 6 | 9.0 | 4.2 | 3.3 | 1.2 | 6.5 | 4.0 | < 0.20 |
| Bladder (C67) | 101 | 5 | 9 | 8 | 8.7 | 2.3 | 3.2 | 0.6 | 5.8 | 3.0 | < 0.20 |
| Lymphoma (C81–85,88,90,96) | 100 | 8 | 10 | 7 | 8.6 | 3.7 | 3.2 | 1.0 | 6.3 | 3.1 | < 0.10 |
| Pancreas (C25) | 50 | 0 | 11 | 11 | 4.3 | 0.0 | 1.6 | 0.0 | 3.1 | 0.1 | < 0.01 |
| Larynx (C32) | 39 | 4 | 12 | 9 | 3.4 | 1.9 | 1.3 | 0.5 | 2.4 | 1.6 | |
| Gallbladder (C23–24) | 38 | 4 | 13 | 9 | 3.3 | 1.9 | 1.2 | 0.5 | 2.4 | 1.6 | |
| Thyroid (C73) | 29 | 0 | 14 | 11 | 2.5 | 0.0 | 0.9 | 0.0 | 1.9 | 0.1 | < 0.05 |
| Brain (C70–72) | 27 | 9 | 15 | 6 | 2.3 | 4.2 | 0.9 | 1.2 | 2.0 | 4.5 | < 0.05 |
| Nasopharynx (C11) | 21 | 5 | 16 | 8 | 1.8 | 2.3 | 0.7 | 0.6 | 1.3 | 2.1 | |
| Bone (C40–41) | 14 | 9 | 17 | 6 | 1.2 | 4.2 | 0.4 | 1.2 | 0.9 | 4.1 | < 0.01 |
| All Male Cancer | 3114 | 775 | 269.1 | 359.5 | 100.0 | 100.0 | 187.5 | 325.2 | < 0.01 | ||
| Female | |||||||||||
| Breast (C50) | 726 | 36 | 1 | 5 | 59.6 | 18.2 | 28.7 | 6.6 | 45.5 | 13.8 | < 0.01 |
| Lung (C33–34) | 346 | 46 | 2 | 4 | 28.4 | 23.1 | 13.7 | 8.4 | 19.0 | 20.8 | |
| Colorectal (C18–21) | 260 | 22 | 3 | 7 | 21.4 | 11.1 | 10.3 | 4.0 | 14.9 | 9.3 | < 0.05 |
| Stomach (C16) | 137 | 166 | 4 | 1 | 11.3 | 83.2 | 5.4 | 30.3 | 7.7 | 71.5 | < 0.01 |
| Cervix (C53) | 132 | 64 | 5 | 3 | 10.8 | 32.1 | 5.2 | 11.7 | 8.4 | 25.0 | < 0.01 |
| Corpus uteri (C54) | 126 | 18 | 6 | 8 | 10.4 | 9.0 | 5.0 | 3.3 | 7.9 | 7.0 | |
| Ovary (C56) | 112 | 6 | 7 | 11 | 9.2 | 3.0 | 4.4 | 1.1 | 7.0 | 2.1 | < 0.05 |
| Lymphoma (C81–85,88,90,96) | 93 | 6 | 8 | 11 | 7.6 | 3.0 | 3.7 | 1.1 | 5.5 | 2.5 | < 0.10 |
| Esophagus (C15) | 79 | 86 | 9 | 2 | 6.5 | 43.1 | 3.1 | 15.7 | 4.1 | 36.2 | < 0.01 |
| Liver (C22) | 74 | 30 | 10 | 6 | 6.1 | 15.0 | 2.9 | 5.5 | 4.2 | 13.3 | < 0.01 |
| Leukemia (C91–95) | 66 | 8 | 11 | 10 | 5.4 | 4.0 | 2.6 | 1.5 | 4.6 | 5.3 | |
| Thyroid (C73) | 60 | 2 | 12 | 15 | 4.9 | 1.0 | 2.4 | 0.4 | 3.9 | 0.8 | < 0.05 |
| Kidney (C64–66,68) | 60 | 1 | 12 | 16 | 4.9 | 0.5 | 2.4 | 0.2 | 3.9 | 0.5 | < 0.05 |
| Pancreas (C25) | 44 | 2 | 13 | 15 | 3.6 | 1.0 | 1.7 | 0.4 | 2.4 | 0.8 | < 0.10 |
| Bladder (C67) | 21 | 4 | 14 | 13 | 1.7 | 2.0 | 1.7 | 0.2 | 1.4 | 2.0 | |
| Gallbladder (C23–24) | 20 | 5 | 15 | 12 | 1.6 | 2.5 | 0.8 | 0.9 | 1.3 | 2.3 | |
| Brain (C70–72) | 12 | 18 | 16 | 8 | 1.0 | 9.0 | 0.5 | 3.3 | 1.0 | 7.3 | < 0.01 |
| Bone (C40–41) | 11 | 9 | 17 | 9 | 0.9 | 4.5 | 0.4 | 1.6 | 0.8 | 4.0 | < 0.01 |
| Nasopharynx (C11) | 9 | 0 | 18 | 17 | 0.7 | 0.0 | 0.4 | 0.0 | 0.7 | 0.0 | |
| Larynx (C32) | 1 | 3 | 19 | 14 | 0.1 | 1.5 | 0.0 | 0.5 | 0.1 | 1.1 | < 0.01 |
| All Female Cancer | 2527 | 547 | 207.6 | 274.2 | 100.0 | 100.0 | 150.4 | 230.7 | < 0.01 | ||
†
Calculated using the approximate method for the comparison of incidence of a disease in two groups as described in Esteve et al. 1994.7
ASR, age‐standardized incidence rate; RSX, rural Shexian; USZ, urban Shijiazhuang.